Effects of Recombinant Human Glutamic Acid Decarboxylase on the Progression of Type 1 Diabetes in New Onset Subjects
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Diane Wherrett, M.D.
University of Toronto, Hospital for Sick Children
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital for Sick Children
Toronto, Ontario, Canada
- Childrens Hospital of Los Angeles
Los Angeles, California, United States
- Stanford University
Palo Alto, California, United States
- University of California-San Francisco
San Francisco, California, United States
- Barbara Davis Center for Childhood Diabetes/university of Colorado Health Sciences Center
Aurora, Colorado, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- University of Florida
Gainesville, Florida, United States
- University of Miami/ Miller School of Medicine
Miami, Florida, United States
- Indiana University School of Medicine
Indianapolis, Indiana, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Columbia University
New York, New York, United States
- Childrens Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
- University of Texas/southwestern Medical School
Dallas, Texas, United States
- Benaroya Research Institute
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 31 May 2012
- Completion
- 31 May 2012
- Last update posted
- 7 May 2020
- Registered enrollment
- 145
- Registry id
- NCT00529399
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.